PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Braun, F.* ; Bertoletti, N.* ; Möller, G. ; Adamski, J. ; Frotscher, M.* ; Guragossian, N.* ; Madeira Gírio, P.A.* ; Le Borgne, M.* ; Ettouati, L.* ; Falson, P.* ; Müller, S.* ; Vollmer, G.* ; Heine, A.* ; Klebe, G.* ; Marchais-Oberwinkler, S.*

Structure-based design and profiling of novel 17 beta-HSD14 inhibitors.

Eur. J. Med. Chem. 155, 61-76 (2018)
Postprint DOI PMC
Open Access Green
The human enzyme 17 beta-hydroxysteroid dehydrogenase 14 (17 beta-HSD14) oxidizes the hydroxyl group at position 17 of estradiol and 5-androstenediol using NAD(+) as cofactor. However, the physiological role of the enzyme remains unclear. We recently described the first class of nonsteroidal inhibitors for this enzyme with compound 1 showing a high 17 beta-HSD14 inhibitory activity. Its crystal structure was used as starting point for a structure-based optimization in this study. The goal was to develop a promising chemical probe to further investigate the enzyme. The newly designed compounds revealed mostly very high inhibition of the enzyme and for seven of them the crystal structures of the corresponding inhibitor enzyme complexes were resolved. The crystal structures disclosed that a small change in the substitution pattern of the compounds resulted in an alternative binding mode for one inhibitor. The profiling of a set of the most potent inhibitors identified 13 (K-i = 9 nM) with a good selectivity profile toward three 17 beta-HSDs and the estrogen receptor alpha. This inhibitor displayed no cytotoxicity, good solubility, and auspicious predicted bioavailability. Overall, 13 is a highly interesting 17 beta-HSD14 inhibitor, which might be used as chemical probe for further investigation of the target enzyme.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.816
1.531
5
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords 17β-hydroxysteroid Dehydrogenase Type 14 ; Crystallography ; Inhibitors ; Structure-based Design; Rheum-rhaponticum Err-731(r); Enzyme-catalyzed Reactions; Alzheimers-disease; Crystal-structures; Special Extract; 17-beta-hydroxysteroid-dehydrogenase; Beta; Activation; Expression; Aglycones
Language english
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 0223-5234
e-ISSN 1768-3254
Journal European Journal of Medicinal Chemistry
Quellenangaben Volume: 155, Issue: , Pages: 61-76 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Reviewing status Peer reviewed
Institute(s) Institute of Experimental Genetics (IEG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-500600-001
DOI 10.1016/j.ejmech.2018.05.029
WOS ID WOS:000441856300006
Scopus ID 85047641283
PubMed ID 29859505
Erfassungsdatum 2018-06-04
[➜Report correction]